Lyka Labs Limited LYKALABS.BO Stock
Lyka Labs Limited Price Chart
Lyka Labs Limited LYKALABS.BO Financial and Trading Overview
| Lyka Labs Limited stock price | 123.7 INR |
| Previous Close | 108.7 INR |
| Open | 106.6 INR |
| Bid | 112.4 INR x 0 |
| Ask | 113.2 INR x 0 |
| Day's Range | 106.6 - 114.2 INR |
| 52 Week Range | 89 - 155.65 INR |
| Volume | 13.85K INR |
| Avg. Volume | 8.26K INR |
| Market Cap | 3.72B INR |
| Beta (5Y Monthly) | 0.999 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -1.23 INR |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
LYKALABS.BO Valuation Measures
| Enterprise Value | 3.92B INR |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 4.262235 |
| Price/Book (mrq) | 5.0100293 |
| Enterprise Value/Revenue | 4.488 |
| Enterprise Value/EBITDA | 37.763 |
Trading Information
Lyka Labs Limited Stock Price History
| Beta (5Y Monthly) | 0.999 |
| 52-Week Change | N/A |
| S&P500 52-Week Change | N/A |
| 52 Week High | 155.65 INR |
| 52 Week Low | 89 INR |
| 50-Day Moving Average | 113.36 INR |
| 200-Day Moving Average | 113.36 INR |
LYKALABS.BO Share Statistics
| Avg. Volume (3 month) | 8.26K INR |
| Avg. Daily Volume (10-Days) | 5.88K INR |
| Shares Outstanding | 33.09M |
| Float | 12.69M |
| Short Ratio | N/A |
| % Held by Insiders | 48.86% |
| % Held by Institutions | 2.67% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | March 31, 2023 |
| Most Recent Quarter (mrq) | September 30, 2023 |
| Next Fiscal Year End | March 31, 2024 |
Profitability
| Profit Margin | -18.056% |
| Operating Margin (ttm) | 2.08% |
| Gross Margin | 57.79% |
| EBITDA Margin | 11.88% |
Management Effectiveness
| Return on Assets (ttm) | -0.60% |
| Return on Equity (ttm) | -39.16% |
Income Statement
| Revenue (ttm) | 872.62M INR |
| Revenue Per Share (ttm) | 36.95 INR |
| Quarterly Revenue Growth (yoy) | 9.59% |
| Gross Profit (ttm) | 555.18M INR |
| EBITDA | 103.72M INR |
| Net Income Avi to Common (ttm) | -158651008 INR |
| Diluted EPS (ttm) | -5.41 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 41.81M INR |
| Total Cash Per Share (mrq) | 1.38 INR |
| Total Debt (mrq) | 540.63M INR |
| Total Debt/Equity (mrq) | 79.23 INR |
| Current Ratio (mrq) | 1.555 |
| Book Value Per Share (mrq) | 22.435 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -67851000 INR |
| Levered Free Cash Flow (ttm) | -58553876 INR |
Profile of Lyka Labs Limited
| Country | India |
| State | N/A |
| City | Mumbai |
| Address | Spencer Building |
| ZIP | 400036 |
| Phone | 91 22 6611 2200 |
| Website | https://www.lykalabs.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 296 |
Lyka Labs Limited, a pharmaceutical company, develops, manufactures, and markets pharmaceutical formulations and active pharmaceutical ingredients across various therapeutic segments in India. The company manufactures and sells various formulations, including emollient, topical steroid, antifungal agent, topical anti-bacterial, acne management, dermatological formulation, pain killer, anti-aging, cleansing lotion, hair care, anti-dandruff shampoo, sunscreen, anti-acne, cosmeceutical, anti-oxidant, proton pump inhibitor, anti-malarial, anti-bacterial, corticosteroid hormones, cephalosporin, dry powder injection, bone resorption inhibitor, anti-oxidant/liver disease, antibiotic, and lyophilized products. It also offers contracted manufacturing services to various large pharmaceutical companies; and medical and technical assistance in the areas of manufacturing know how and manufacturing facilities, as well as technical data, such as molecule stability testing data, impurity profile, and BA/BE clinical study data. In addition, it provides products and services in therapeutic categories, such as intensive care, gastroenterology, anti-infective, anti-fungal, surgery care, cosmetologist, urology, wound care, and anesthesia. The company offers its products in various forms, including injections, creams, ointments, foams, gels, and lotions. It also exports its products. Lyka Labs Limited was incorporated in 1976 and is based in Mumbai, India.
Q&A For Lyka Labs Limited Stock
What is a current LYKALABS.BO stock price?
Lyka Labs Limited LYKALABS.BO stock price today per share is 123.7 INR.
How to purchase Lyka Labs Limited stock?
You can buy LYKALABS.BO shares on the BSE exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Lyka Labs Limited?
The stock symbol or ticker of Lyka Labs Limited is LYKALABS.BO.
Which industry does the Lyka Labs Limited company belong to?
The Lyka Labs Limited industry is Biotechnology.
How many shares does Lyka Labs Limited have in circulation?
The max supply of Lyka Labs Limited shares is 33.09M.
What is Lyka Labs Limited Price to Earnings Ratio (PE Ratio)?
Lyka Labs Limited PE Ratio is now.
What was Lyka Labs Limited earnings per share over the trailing 12 months (TTM)?
Lyka Labs Limited EPS is -1.23 INR over the trailing 12 months.
Which sector does the Lyka Labs Limited company belong to?
The Lyka Labs Limited sector is Healthcare.